References
- 1. Slavica Đukić Dejanović, Vladimir Janjić, Goran Mihajlović, Danijela Đoković, Dragana Ignjatović Ristić, Dragan Ravanić i saradnici, Psihijatrija, Medicinski fakultet Univerziteta u Kragujevcu, 2011; str. 271-282.
- 2. Grams ME, Chow EK, Segev DL, Coresh J. Lifetime incidence of CKD stages 3-5 in the United States. Am J Kidney Dis. 2013; 62(2):245-52.10.1053/j.ajkd.2013.03.009
- 3. Bowling CB, Muntner P, Sawyer P, Sanders PW, Kutner N, et al. Community mobility among older adults with reduced kidney function: a study of life-space. Am J Kidney Dis. 2014; 63(3):429-36.10.1053/j.ajkd.2013.07.022
- 4. Sarnak MJ, Tighiouart H, Scott TM, Lou KV, Sorensen EP, Giang LM, et al. Frequency of and risk factors for poor cognitive performance in hemodialysis patients. Neurology. 2013; 80(50):471-80.10.1212/WNL.0b013e31827f0f7f
- 5. Pereira AA, Weiner DE, Scott T, Sarnak MJ. Cognitive function in dialysis patients. Am J Kidney Dis. 2005; 45(3):448-62.10.1053/j.ajkd.2004.10.024
- 6. Sehgal AR, Grey SF, DeOreo PB, Whitehouse PJ. Prevalence, recognition, and implications of mental impairment among hemodialysis patients. Am J Kidney Dis. 1997; 30(1):41-9.10.1016/S0272-6386(97)90563-1
- 7. Kutlay S, Nergizoglu G, Duman N, Atli T, Keven K, Ertürk S, et al. Recognition of neurocognitive dysfunction in chronic hemodialysis patients. Ren Fail. 2001; 23(6):781-7.
- 8. Moss AH. Shared decision-making in dialysis: the new RPA/ASN guideline on appropriate initiation and withdrawal of treatment. Am J Kidney Dis. 2001; 37(5):1081-91.
- 9. Griva K, Stygall J, Hankins M, Davenport A, Harrison M, Newman SP. Cognitive impairment and 7-year mortality in dialysis patients. Am J Kidney Dis. 2010; 56(4):693-703.10.1053/j.ajkd.2010.07.003
- 10. Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, et al. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med. 2004; 6:140(7):501-9.
- 11. Tschanz JT, Corcoran C, Skoog I, Khachaturian AS, Herrick J, Hayden KM, et al. Cache County Study Group. Dementia: the leading predictor of death in a defined elderly population:the Cache County Study. Neurology. 2004; 62(7):1156-62.10.1212/01.WNL.0000118210.12660.C2
- 12. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005; 53(4):695-9.10.1111/j.1532-5415.2005.53221.x
- 13. Tiffin-Richards FE, Costa AS, Holschbach B, Frank RD, Vassiliadou A, Krüger T et al. The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients. PLoS One. 2014;9(10):e106700
- 14. Yaffe K, Ackerson L, Kurella Tamura M, Le Blanc P, Kusek JW, Sehgal AR, et al.; Chronic Renal Insufficiency Cohort Investigators. Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc. 2010; 58(2):338-45.10.1111/j.1532-5415.2009.02670.x
- 15. Montreal Cognitive Assessment test, MoCA test as published online: http://www.mocatest.org/faq/
- 16. Murray AM. Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden. Adv Chronic Kidney Dis. 2008; 15(2):123-32.
- 17. Paraizo MA, Almeida AL, Pires LA, Abrita RS, Crivellari MH, Pereira BD, et al. Montreal Cognitive Assessment (MoCA) screening mild cognitive impairment in patients with chronic kidney disease (CKD) predialysis. J Bras Nefrol. 2016; 38(1):31-41.
- 18. Yaffe K, Petersen RC, Lindquist K, Kramer J, Miller B. Subtype of mild cognitive impairment and progression to dementia and death. Dement Geriatr Cogn Disord. 2006; 22(4):312-9.10.1159/000095427
- 19. Price CC, Cunningham H, Coronado N, Freedland A, Cosentino S, Penney DL, et al. Clock drawing in the Montreal Cognitive Assessment: recommendations for dementia assessment. Dement Geriatr Cogn Disord. 2011;31(3):179-87.10.1159/000324639
- 20. Cecato JF, Martinelli JE, Izbicki R, Yassuda MS, Aprahamian I. A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer’s disease? Int Psychogeriatr. 2016; 28(5):825-32.10.1017/S1041610215001982
- 21. Pliskin NH, Yurk HM, Ho LT, Umans JG. Neurocognitive function in chronic hemodialysis patients. Kidney Int. 1996; 49(5):1435-40.
- 22. Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, et al. Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch Neurol. 2004; 61(5):668-72.
- 23. Bredesen DE. Metabolic profiling distinguishes three subtypes of Alzheimer’s disease. Aging (Albany NY). 2015; 7(8):595-600.
- 24. Teunissen CE, van Boxtel MP, Bosma H, Bosmans E, Delanghe J, De Bruijn C, et al. Inflammation markers in relation to cognition in a healthy aging population. J Neuroimmunol. 2003; 134(1-2):142-50.
- 25. Watanabe Y, Kitamura K, Nakamura K, Sanpei K, Wakasugi M, Yokoseki A, et al. Elevated C-Reactive Protein Is Associated with Cognitive Decline in Outpatients of a General Hospital: The Project in Sado for Total Health (PROST). Dement Geriatr Cogn Dis Extra. 2016; 19;6(1):10-9.
- 26. Roman SA, Sosa JA, Mayes L, Desmond E, Boudourakis L, Lin R, et al. Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism. Surgery. 2005; 138(6):1121-8.
- 27. Walker MD, McMahon DJ, Inabnet WB, Lazar RM, Brown I, Vardy S, et al. Neuropsychological features in primary hyperparathyroidism: a prospective study. J Clin Endocrinol Metab. 2009; 94(6):1951-8.
- 28. Papageorgiou SG, Christou Y, Kontaxis T, Bonakis A, Anagnostouli M, Potagas C, et al. Dementia as presenting symptom of primary hyperparathyroidism: favourable outcome after surgery. Clin Neurol Neurosurg. 2008; 110(10):1038-40.
- 29. Chou FF, Chen JB, Hsieh KC, Liou CW. Cognitive changes after parathyroidectomy in patients with secondary hyperparathyroidism. Surgery. 2008; 143(4):526-32.
- 30. Björkman MP, Sorva AJ, Tilvis RS. Does elevated parathyroid hormone concentration predict cognitive decline in older people? Aging Clin Exp Res. 2010; 22(2):164-9.10.1007/BF03324791
- 31. Drew DA, Bhadelia R, Tighiouart H, Novak V, Scott TM, Lou KV, et al. Anatomic brain disease in hemodialysis patients: a cross-sectional study. Am J Kidney Dis. 2013; 61(2):271-8.
- 32. Prohovnik I, Post J, Uribarri J, Lee H, Sandu O, Langhoff E. Cerebrovascular effects of hemodialysis in chronic kidney disease. J Cereb Blood Flow Metab. 2007; 27(11):1861-9.
- 33. Narumoto J, Matsushima N, Oka S, Shimizu H, Kooguchi Y, Kitabayashi Y, et al. Neurobehavioral changes associated with bilateral caudate nucleus infarctions. Psychiatry Clin Neurosci. 2005; 59(1):109-10.
- 34. Murray AM. Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden. Adv Chronic Kidney Dis. 2008; 15(2):123-32.